PSEN1 and Alzheimer disease: Collectively, the data reveal novel role of PS1 and Syt1 at the synapse; present a reduction in the PS1-Syt1 interactions as potential molecular contributor to AD pathogenesis; and open avenues for novel synapse-specific AD-targeting therapeutic interventions.